US equities push to fresh records as the AI rally re-accelerates and Goldman’s chief flags more greed than fear in the tape — though the yen sliding toward 160 and a private-credit fund hit by 17% redemptions keep a note of caution · Trump’s friction with Netanyahu is now the main hurdle to an Iran deal, with fresh US–Iran strikes straining the ceasefire and oil bid near $95 · Trump rebuilds a tariff wall with proposed 10% levies · SpaceX targets a $75bn listing.
Europe/Rome 06:00 · Markets open · pre-US-open · Risk-on · records, but froth building
Levels below are the Bloomberg Europe live ticker read at ~06:00 Rome. US indices reflect the latest close — the session that extended the AI-led record rally — while FTSE, FX and commodities are live. The week’s decisive data lands later: the US May jobs report on Friday (5 June) and the ECB decision on 11 June are the next big rates events.
Top of the morning
Trump’s rift with Netanyahu becomes the main obstacle to an Iran deal
Bloomberg’s lead geopolitics story frames Israel’s insistence on pressing its own war aims as the key thing undercutting Trump’s grip on how the Iran conflict ends. Overnight, the US and Iran traded fresh military strikes that put new strain on the shaky ceasefire, traffic through the Strait of Hormuz stayed thin amid the uncertainty, and reporting flagged the conflict rippling into global food supply chains. Crude held a bid near $95.
Stocks extend their record rally on AI — and the yen slides toward 160
The markets wrap has equities pushing further into record territory on AI leadership, with Goldman chief David Solomon publicly judging there is more greed than fear in the tape — a candid read on how strong risk appetite has become. The counterweight is in currencies: the yen is closing on the 160 line, reviving the question of where Tokyo’s intervention pain threshold sits. Goldman also lifted its Kospi target toward 12,000 and upgraded Taiwan, keeping the Asia-tech bid alive.
Trump rebuilds the tariff wall with proposed 10% levies
Washington is floating duties of at least 10% on imports from a long list that includes Canada, Mexico, the EU, Taiwan and the UK, even as it appeals a trade-court order that would force broad refunds of earlier IEEPA tariffs — and selectively trims some rates to try to spur investment. The mixed signals keep trade policy a live macro risk for European exporters and supply chains.
SpaceX targets a $75bn IPO as the listings boom widens
SpaceX is reported to be seeking about $135 a share in a roughly $75bn offering, a trimmed valuation target, with staff angling for favourable terms ahead of a windfall. It lands alongside Anthropic’s confidential filing and a broader rush — including retail investors chasing pre-IPO exposure in private markets — that points to a very heavy issuance year.
Private-credit stress: a flagship fund hit by 17% redemption requests
A Bloomberg exclusive reports a Cliffwater private-credit fund facing redemption requests near 17%, as separate coverage describes retail investors edging toward the exits across the asset class. It is the morning’s clearest crack in an otherwise risk-on tape — a watch item for the credit cycle rather than, yet, a systemic event.
NATO ‘harder to manage’ as the US weighs wider nuclear deployments in Europe
Former secretary-general Jens Stoltenberg warned the alliance is now more difficult to hold together and that there are limits to what Europe should accept from Washington, while urging Norway’s $2.3tn wealth fund to stay invested in big tech. In parallel, FT reports the US has signalled openness to basing nuclear-capable bombers in more countries — a meaningful escalation in the European-security debate.
Health watch: a harder-to-contain Ebola, and a multi-billion NYU hospital
A Bloomberg feature argues the world’s Ebola playbook is poorly suited to the current strain — a clinically important reminder that preparedness built for past outbreaks may not transfer. On the infrastructure side, NYU Langone is set to build a new multi-billion-dollar hospital on Long Island. Quiet but consequential reading for the medical sector.
FT portfolio signal · tied to your holdings
What FT flagged for your book
Macro / regime read. The dominant thread this morning is froth, not fear. myFT instant alerts cluster around a record-chasing tape and a wall of supply: Goldman’s chief seeing more greed than fear, an Unhedged piece on roughly $675bn of fresh tech equity on offer, and calls for a “mammoth” IPO year — with SpaceX’s $75bn listing and Anthropic’s filing as the marquee names. Against that sit two cautions the dashboard cares about: a credit-stress flag (a private-credit fund facing ~17% redemptions, retail eyeing the exits) and a firmer-rates, weak-yen backdrop (US 10-year near 4.46%, yen toward 160). Ruchir Sharma’s “American profit machine” column and a fragile US–China chip truce reinforce the “respect the froth” framing. The credit flag is a watch item, not a severe trigger — the war-chest deployment rules stay dormant.
Microsoft (shelf single-name hit). A myFT Microsoft alert says the company is squaring up to Anthropic with new model releases, with AI chief Mustafa Suleyman framing the focus as products for business users. Read-through: MSFT is pressing its enterprise-AI / Azure advantage as foundation-model competition intensifies — supportive of the capex-and-cloud thesis, with rivalry the thing to monitor.
Alphabet (shelf single-name hit). An alert on Alphabet’s ~$80bn equity raise underscores the sheer scale of AI-capex financing now in train. It is real dilution, but it funds the build-out behind the thesis; the signal is conviction in the AI cycle, with capital absorption the watch.
Semiconductors / AI capex (theme hits). Chris Miller on the fragile US–China tech truce and Robert Armstrong on AI’s GDP impact and the chip cycle both bear on the picks-and-shovels case behind your ASML, Broadcom, Microsoft/Azure, Alphabet shelf. Nvidia’s new push into laptop silicon adds to the cycle; the supply-chain and geopolitical risk is the offset to respect.
Pharma colour (no single-name hit). The pharma alert skewed to Roche’s struggle to reinvent its once-dominant oncology franchise — sector context only, with no direct read on Novo Nordisk, Eli Lilly, Vertex, UnitedHealth, Thermo Fisher or Intuitive.
Shelf single-names: today’s live alerts are Microsoft and Alphabet. No GLP-1 / Novo Nordisk / Eli Lilly / Vertex / UnitedHealth / Intuitive / Visa / Mastercard / Berkshire single-name FT items in the window. (Name-level alerts only surface here once FT routes them to this Gmail — see the iCloud→Gmail forwarding note if they stay sparse.)
Net: the AI-capex tailwind is re-accelerating to records and two shelf names (MSFT, Alphabet) are in the news for the right reasons — but the greed signal is loud, supply is heavy, and the private-credit crack persists. Regime = risk-on, watch credit and rates; not a deploy trigger. Friday’s US payrolls and the 11 June ECB are the swing events.
Markets snapshot
Bloomberg Europe live ticker at ~06:00 Rome. US indices are the latest close (record rally); FTSE, FX and commodities live. Daily % changes as shown on the ticker.
Instrument
Last
Change / context
S&P 500
7,609.78
+0.13% · fresh record on AI
Nasdaq
27,093.90
+0.03% · AI leadership holds
Bloomberg 500
2,753.76
+0.19%
FTSE 100
10,373.51
+0.33%
US 10-year Treasury
4.46%
yields firmer · rates a quiet headwind
EUR/USD
~1.16
+0.03% · little changed
GBP/USD
~1.35
+0.02%
Crude Oil
$94.76
+1.07% · Iran/Hormuz premium building
Gold (spot)
$4,512.70
+0.16% · hedge bid steady
Figures transcribed from the Bloomberg Europe “Top Securities” ticker; FX shown to two decimals as on the ticker. Yen quoted in narrative as approaching 160 per the markets-wrap headline.
Global markets & macro
The tape is back in record-chasing mode. Bloomberg’s lead has equities extending their AI-led rally, and the mood is captured bluntly by Goldman’s David Solomon, who sees more greed than fear in markets — a candid acknowledgement of how stretched risk appetite has become. The supply side is doing its part to feed it: SpaceX is lining up a ~$75bn IPO, Anthropic has filed confidentially, Alphabet is raising up to $80bn in equity for its build-out, and Unhedged tallies roughly $675bn of fresh tech stock heading to hungry investors. The contrarian flags are getting louder in proportion — a Ruchir Sharma column arguing US corporate profitability is no stronger than at the dotcom peak, 19 newly minted AI billionaires, and the first real crack in private credit, where a Cliffwater fund is fielding redemption requests near 17% and retail money is starting to eye the exits.
Rates and currencies are the quieter, firmer sub-plots. The US 10-year sits near 4.46% as a regime change takes shape at the Fed under Kevin Warsh, who has just named conservative advisers — a shift markets are still learning to price. In FX, the yen edging toward 160 is the standout, putting Tokyo’s intervention calculus back in focus, while the euro (~1.16) and sterling (~1.35) are little changed. Asia offered a constructive backdrop: Goldman lifted its Kospi target toward 12,000 and upgraded Taiwan to buy, China’s May services activity picked up on a holiday boost, and the region’s AI-wealth story rolled on as a TikTok-linked fortune overtook Mukesh Ambani. Commodities keep a geopolitical tilt — crude firmer near $95 on the Iran premium, gold steady around $4,510 — with Friday’s US payrolls the week’s decisive print.
Geopolitics & world news
The Iran track is the morning’s dominant risk, and it has turned more tangled than tense. Bloomberg frames Israel’s determination to pursue its own objectives as the main thing limiting Trump’s control over how the conflict ends — a friction between the two leaders that is now the chief obstacle to a durable deal. Overnight the US and Iran exchanged fresh strikes that strained the ceasefire, traffic through the Strait of Hormuz remained thin while a peace deal hangs in the balance, and the war is increasingly visible in global food supply chains. Markets read it through oil, which holds a premium near $95, and gold, which keeps a steady hedge bid. Layered on top is Trump’s tariff push — proposed 10% levies on a broad set of partners, a court appeal over earlier duties, and selective rate cuts pitched as pro-investment.
Europe’s security debate is sharpening. Stoltenberg’s warning that NATO is harder to manage — and that Europe must set limits with Washington — lands as the US signals openness to basing nuclear-capable bombers in more countries, and as the EU moves to strengthen its own tech base against both the US and China. Elsewhere, Russia’s state is seizing assets from an expanding list of billionaires, raising fears over who is next, and a pro-Trump outsider advanced in Colombia’s vote. For the medical reader, the standout is clinical: a feature arguing the world’s Ebola preparedness is mismatched to the current strain, alongside NYU Langone’s plan for a new multi-billion-dollar Long Island hospital — signals worth tracking for public health and the healthcare-investment landscape.
Today & week ahead (CET)
Wed 3US ISM services & ADP private payrolls · China services data (picked up in May) — the payrolls warm-up
Wed 3SpaceX IPO pricing watch (~$135/share, ~$75bn) · Iran–Israel ceasefire monitoring after the overnight strike exchange · tariff/IEEPA appeal headlines
Thu 4US weekly jobless claims · ECB speakers into the blackout · euro-area PPI
Fri 5US May jobs report — payrolls and unemployment, the week’s marquee print for the Fed-path debate under Warsh
Wed 11ECB rate decision — data-dependent; a hike not ruled out (next week)
WatchAI / IPO-supply froth & the greed-vs-fear debate · oil on Iran–Hormuz headlines · private-credit redemptions · yen toward 160 / BoJ intervention · Fed regime change under Warsh